The Latin America, Middle East and Africa Cold And Flu Supplements Market would witness market growth of 13.8% CAGR during the forecast period (2023-2030).
The demand for cold and flu supplements is rising due to increased focus on disease prevention and immune system building. Immune system enhancement is the primary goal of these supplements. The market is predicted to expand steadily due to rising consumer awareness of the benefits of these products. There is a sizable market for supplements and goods that promise to improve natural health or immunity. The needs of the customer are highlighted. The two most popular cold and flu supplements are capsules and pills. Also, brand extensions and product innovation have fueled the expansion of the market.
Due to their compromised immune systems, older people are more prone to getting the flu and colds. With the help of supplements, people can easily strengthen their immune systems and stay healthy. Sales may be influenced by this convenience factor, particularly among busy people. The popularity of self-care and holistic wellness has raised demand for goods that promote overall health, including immunological function. The trend for cold and flu supplements may fit well.
Consumer health systems are becoming a growing source of concern. A vital component of people's hectic lifestyles is an immune health supplement. The use of immune health supplements is supported by consumers nowadays, such as those who maintain a healthy, balanced diet. The region also has a thriving pharmaceutical industry, which helps to sustain the selling of cold and flu supplements. Other factors influencing market expansion in these areas include rising healthcare spending, more consumer knowledge of health supplements, and an increased desire for natural and organic goods. Consumers in the region feel that they need to boost their immune systems to prevent the unpleasant effects of infectious diseases like the seasonal flu. Vitamins A, B2, B6, and C are a few of the immune health supplements that might help strengthen the body's defense.
The Brazil market dominated the LAMEA Cold And Flu Supplements Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $575.8 million by 2029. The Argentina market is estimated to grow at a CAGR of 14.5% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 13.5% during (2023 - 2030).
Based on Product, the market is segmented into Vitamins & Minerals, Herbal Extracts, and Natural Molecules. Based on Distribution Channel, the market is segmented into Pharmacies & Drug Stores, Hypermarkets & Supermarkets, Online, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Cold And Flu Supplements Market is Projected to reach USD 35.5 Billion by 2030, at a CAGR of 11.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Nordic Naturals, Inc., Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer, Inc., Amway Corporation, NOW Foods, Inc., Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.), Neurobiologix, Inc., Himalaya Global Holdings Ltd., Nu Skin Enterprises, Inc., and Nature’s Sunshine Products, Inc.
By Product
By Distribution Channel
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
